Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy

Table 7 Clinicopathologic features in ovarian cancer patients according to Tau expression

Clinical parameter	Negative Tau expression	Positive Tau expression	p value
Age
o < 65	16	44	p= ,8496*
o ≥ 65	4	10	p= ,8496*
FIGO stage at diagnosis
o Early (I,II)	7	10	p= ,1345
o Advanced (III,IV)	13	44	p= ,1345
Histopathologic cell type
o Serous	8	29	p= ,2951
o others	12	25	p= ,2951
Performance status (ECOG)
o 0-1	19	50	p= ,8768*
o 2	1	4	p= ,8768*
Tumor grade
o G1,G2	12	19	p= ,0547
o G3, unknown	8	35	p= ,0547

ISSN: 1756-9966